-
FDA Votes In Favor Of Pfizer's Maternal RSV Vaccine To Prevent Disease In Infants
Friday, May 19, 2023 - 9:00am | 419Read More...The U.S. Food and Drug Administration (FDA) voted that the available data support the efficacy and safety of Pfizer Inc's (NYSE: PFE) unadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F vaccine candidate RSVpreF or PF-06928316. The FDA's Vaccines and...
-
Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters
Wednesday, March 17, 2021 - 12:40pm | 254Read More...According to a small study conducted in Israel, pregnant women vaccinated against COVID-19 could pass along protection to their babies, Reuters reported. In the research conducted in February, antibodies were detected in all 20 women who got both doses of the Pfizer Inc (NYSE) /...
